Stephen C. Glover - Director at Ambrx Biopharma Cayman, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AMAM
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen C. Glover since 04 Feb 2025

Holdings reported by Stephen C. Glover for Ambrx Biopharma Cayman, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 85,000 $907,197 $10.67 07 Jun 2023 Direct
Stock Option (right to buy) 17,500 18 May 2023 Direct Ordinary Shares

Transactions reported by Stephen C. Glover for Ambrx Biopharma Cayman, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.